Gates Foundation faces criticism over COVID 19 vaccine access
The Gates Foundation relying on Gavi and COVAX faced critique for patent protections and slow vaccine distribution to low and middle income countries. Critics argue exclusive licensing limited production while supporters cite billions invested in vaccines and global health.
MENTIONED IN THIS ARTICLE
Seattle
Bill & Melinda Gates Foundation
Gavi
Vaccine Alliance
Foundation
COVAX
U.S
Gates Foundation
Trevor Mandel
Bill Gates
Alexander Zaitchik
New Republic
Microsoft
Gates
COVID
Northeastern University Law
Brook Baker
Seattle Times’ Education Lab
Bill and
Melinda Gates
Lawrence Gostin
Georgetown University Law
Gostin
Jain Mukherjee
India
South Africa
Mukherjee
Trump
Serum Institute of India
Biden
World Health Organization
Oxford University
Pharma
Oxford
AstraZeneca
James Love
Knowledge Ecology International
Baker
Violaine Mitchell
Asia Russell
Health Gap
Uganda
Mandel
Also Mentioned on This Page
Oxford/AstraZeneca
Ivato International
Antananarivo
Madagascar
Getty Images
Iowa
The
Gazette
the Guide
Hilton Garden Inn
Cedar Rapids
Iowaweddingexperience.com
Guide Prize
the Gazette
Chelsea Griederchelsea
Debbie Scott
Debbie
Scott
Thegazette